Keyphrases
Systemic Lupus Erythematosus
100%
COVID-19
81%
Rheumatic Diseases
32%
SLE Disease Activity Index (SLEDAI)
24%
Immunogenicity
23%
Hydroxychloroquine
20%
Chronic Inflammatory Diseases
20%
Lupus Nephritis
20%
Rheumatology
19%
SARS-CoV-2 Vaccination
19%
Vaccination
18%
Meta-analysis
17%
COVID-19 Pandemic
17%
Disease Activity
15%
Systemic Lupus
14%
Autoimmune Disease
13%
Rheumatologists
13%
Neutrophils
12%
Systemic Lupus Erythematosus Patient
12%
Proteinuria
12%
Lupus
12%
Immunosuppression
12%
Podocyte
11%
Choroidal Thickness
11%
Foot Process Effacement
11%
Reactogenicity
11%
Belimumab
11%
Systematic Meta-analysis
11%
B Cells
11%
OMERACT
11%
Complement Activation
11%
Immunosuppressed
11%
American College of Rheumatology
10%
Patient Experience
9%
Innate Immune Response
9%
Rheumatology Research
9%
Core Outcome Set
8%
Complement System
8%
Kidney
8%
MRNA Vaccine
8%
Health-related Quality of Life
8%
Macrophages
8%
Thrombotic Microangiopathy
7%
Digital Resources
7%
Disease Flare
7%
CD8+ T Cells
7%
Patient-reported Outcomes
7%
Patients with COVID-19
7%
Disease-associated
7%
Human Disease
6%
Medicine and Dentistry
Systemic Lupus Erythematosus
64%
COVID-19
42%
Rheumatology
28%
Diseases
22%
Disease Activity
21%
Lupus Nephritis
19%
Rheumatic Disease
18%
Lupus Erythematosus
16%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Complement Activation
10%
Quality of Life
9%
Hydroxychloroquine
7%
Infection
7%
Complement System
7%
Neutrophil
7%
Autoimmune Disease
7%
Thrombotic Thrombocytopenic Purpura
7%
Glomerulus
6%
Health Care
6%
Patient Experience
6%
Proteinuria
6%
Microthrombus
5%
Cardiovascular Toxicity
5%
COVID-19 Vaccination
5%
Combination Therapy
5%
Coronavirinae
5%
Sleep Disorder
5%
Biological Marker
5%
Inflammatory Disorder
5%
Podocyte
5%
Symptomatology
5%
Systematic Review
5%
B Cell
5%
Meta-Analysis
5%
Belimumab
5%
Macrophage
5%
Glomerulonephritis
5%
Social Support
5%
Heart Function
5%
T Cell
5%
Diabetes
5%
Myocardial Disease
5%
Interleukin 4
5%
Immunology and Microbiology
Systemic Lupus Erythematosus
38%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
COVID-19
21%
Immunogenicity
20%
Lupus Erythematosus
16%
Inflammatory Arthritis
16%
Cytotoxic T-Cell
13%
B Cell
13%
Neutrophil
12%
Immunosuppression
11%
Inflammatory Disorder
11%
Complement Activation
10%
Complement System
8%
Glomerulus
7%
Arthritis
7%
Spike
7%
Autoimmune Disease
7%
Thrombotic Thrombocytopenic Purpura
7%
Neutralization
6%
T Cell
6%
Innate Immune System
6%
Blood Level
5%
Cellular Distribution
5%
Breakthrough Infection
5%
Complement Component C5a Receptor
5%
IC3b
5%
Human Immunodeficiency Virus
5%
Podocyte
5%
Foot
5%
Immune-Mediated Inflammatory Diseases
5%
Polyclonal Antibody
5%
Freeze Thawing
5%
Cell Antigen
5%
Alveolar Macrophage
5%
Antigen Presentation
5%
Meninx
5%
Glomerulonephritis
5%
Interleukin 15
5%
Autoimmune Rheumatic Disease
5%
Plasmacytoid Dendritic Cell
5%
Chikungunya Virus
5%
ELISA
5%
Seroconversion
5%
Lineages
5%
Tumor Suppressor Gene
5%
Immunoglobulin G1
5%
Immunoglobulin G4 Related Disease
5%
Immune Response
5%
Immunity
5%